☰

Pasha Apontes, Ph.D. - Publications

Affiliations: 
2011 Roswell Park . Cellular and Molecular Biology State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Apontes P, Leontieva OV, Demidenko ZN, Li F, Blagosklonny MV. Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget. 2: 222-33. PMID 21447859 DOI: 10.18632/Oncotarget.248  0.462
2009 Ling X, He X, Apontes P, Cao F, Azrak RG, Li F. Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin. American Journal of Translational Research. 1: 393-405. PMID 19956451  0.503
2007 Wu J, Apontes P, Song L, Liang P, Yang L, Li F. Molecular mechanism of upregulation of survivin transcription by the AT-rich DNA-binding ligand, Hoechst33342: evidence for survivin involvement in drug resistance. Nucleic Acids Research. 35: 2390-402. PMID 17392340 DOI: 10.1093/nar/gkm149  0.466
2005 Wu J, Ling X, Pan D, Apontes P, Song L, Liang P, Altieri DC, Beerman T, Li F. Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity. The Journal of Biological Chemistry. 280: 9745-51. PMID 15637054 DOI: 10.1074/Jbc.M409350200  0.507
2005 Li F, Ling X, Huang H, Brattain L, Apontes P, Wu J, Binderup L, Brattain MG. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene. 24: 1385-95. PMID 15608672 DOI: 10.1038/Sj.Onc.1208330  0.471
Show low-probability matches.